Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $21.74 USD
Change Today +0.47 / 2.21%
Volume 845.3K
MNTA On Other Exchanges
Symbol
Exchange
Frankfurt
As of 5:20 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at momenta pharmaceuticals inc (MNTA)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
Craig Wheeler 76 RelationshipsChief Executive Officer, President and Executive DirectorChief Executive Officer55

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
James Sulat MBA 52 RelationshipsChairman of the BoardMaxygen, Inc.65
John Clarke 90 RelationshipsMember of the Board of DirectorsAlnylam Pharmaceuticals, Inc.61
Bennett Shapiro M.D. 117 RelationshipsMember of the Board of DirectorsPureTech Health PLC75
Marsha Fanucci 62 RelationshipsMember of the Board of DirectorsMomenta Pharmaceuticals Inc.61
Robert Pollock M.S., R.Ph. 32 RelationshipsMember of Advisory BoardLachman Consultant Services, Inc.--
Thomas Garvey III, M.D. 19 RelationshipsMember of Advisory BoardMomenta Pharmaceuticals Inc.--
J. Crout M.D. 21 RelationshipsMember of Advisory BoardMomenta Pharmaceuticals Inc.85
Benito Casu Ph.D. 37 RelationshipsMember of Advisory BoardMomenta Pharmaceuticals Inc.--
Richard Cooper J.D., FDA 19 RelationshipsMember of Advisory BoardMomenta Pharmaceuticals Inc.--
Carolyn Bertozzi Ph.D. 39 RelationshipsMember of Advisory BoardRedwood Bioscience, Inc.--
Eugene Braunwald M.D., M.D. (hon), Sc.D. (hon), F.R.C.P. 41 RelationshipsMember of Advisory BoardMomenta Pharmaceuticals Inc.--
Elliott Antman M.D. 19 RelationshipsMember of Advisory BoardMomenta Pharmaceuticals Inc.--
K. Austen M.D. 59 RelationshipsMember of Advisory BoardMomenta Pharmaceuticals Inc.--
William Reardon CPA 53 RelationshipsMember of Advisory BoardSynta Pharmaceuticals Corp.69
Francis Bullock Ph.D. 63 RelationshipsMember of Advisory BoardExtera Partners, LLC78
Elizabeth Stoner M.D., M.S. 33 RelationshipsMember of the Board of DirectorsRhythm Pharmaceuticals, Inc.65
Phillips Robbins Ph.D. 19 RelationshipsMember of Advisory BoardMomenta Pharmaceuticals Inc.--
Bruce Downey J.D. 56 RelationshipsMember of the Board of DirectorsNewSpring Capital68
Thomas Koestler Ph.D. 59 RelationshipsMember of the Board of DirectorsVatera Healthcare Partners64
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNTA:US $21.74 USD +0.47

MNTA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amarin Corp PLC $2.50 USD -0.02
Amphastar Pharmaceuticals Inc $17.34 USD +0.10
OraSure Technologies Inc $4.92 USD -0.22
SciClone Pharmaceuticals Inc $10.91 USD -0.15
Sucampo Pharmaceuticals Inc $17.07 USD +0.73
View Industry Companies
 

Industry Analysis

MNTA

Industry Average

Valuation MNTA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 23.2x
Price/Book 5.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 24.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOMENTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.